BACKGROUND: Mismatch repair (MMR) genes are known to be frequently altered in colorectal cancer (CRC). Both genetics and epigenetics modifications seems to be relevant in this phenomenon, however it is still not clear how these two aspects are interconnected. The present study aimed at characterizing of epigenetic and gene expression profiles of MMR genes in sporadic CRC patients from the Czech Republic, a country with one of the highest incidences of this cancer all over Europe. METHODS: Expression levels and CpG promoter methylation status of all MMR genes were evaluated in DNA from tumor and adjacent mucosal samples of 53 incident CRC patients. RESULTS: We have found significantly increased transcription levels in EXO1 gene in tumor tissues (P = 0.05) and significant over-expression of MSH3 gene in colon tumors when compared to adjacent mucosal tissues (P = 0.02). Interestingly, almost all MMR genes were differently expressed when localization of tumors was compared. In particular, colon tumors showed an up-regulation of EXO1, MSH2, MSH3, MSH6, and PMS2 genes in comparison to rectal tumors (P = 0.02). Expression levels of all MMR genes positively correlated between each other. The promoter methylation of MLH1 gene was observed in 9% of CRC tissues only. CONCLUSIONS: In our study, we have observed different pattern of MMR genes expression according to tumor localization. However, a lack of association between methylation in MMR genes and their corresponding expressions was noticed in this study, the relationship between these two aspects is worthy to be analyzed in larger population studies and in pre-malignant stages.

Institute of Experimental Medicine Academy of Sciences of the Czech Republic Prague Czech Republic

See more in PubMed

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;15(2):69–90. doi: 10.3322/caac.20107. PubMed DOI

Naccarati A, Pardini B, Landi S, Landi D, Slyskova J, Novotny J, Levy M, Polakova V, Lipska L, Vodicka P. Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk. Carcinogenesis. 2012;15(7):1346–1351. doi: 10.1093/carcin/bgs172. PubMed DOI

Center M, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;15(6):1688–1694. doi: 10.1158/1055-9965.EPI-09-0090. PubMed DOI

Center M, Jemal A, Smith R, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;15(6):366–378. doi: 10.3322/caac.20038. PubMed DOI

Theodoratou E, Montazeri Z, Hawken S, Allum G, Gong J, Tait V, Kirac I, Tazari M, Farrington S, Demarsh A. et al.Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J Natl Cancer Inst. 2012;15(19):1433–1457. doi: 10.1093/jnci/djs369. PubMed DOI

Burgart L. Testing for defective DNA mismatch repair in colorectal carcinoma: a practical guide. Arch Pathol Lab Med. 2005;15(11):1385–1389. PubMed

Arends M. Pathways of colorectal carcinogenesis. Appl Immunohistochem Mol Morphol. 2013;15(2):97–102. PubMed

Curtin K, Slattery M, Samowitz W. CpG island methylation in colorectal cancer: past, present and future. Pathol Res Int. 2011;15:8. Article ID 902674. PubMed PMC

Venkatachalam R, Ligtenberg M, Hoogerbrugge N, de Bruijn D, Kuiper R, Geurts van Kessel A. The epigenetics of (hereditary) colorectal cancer. Cancer Genet Cytogenet. 2010;15(1):1–6. doi: 10.1016/j.cancergencyto.2010.08.013. PubMed DOI

English D, Young J, Simpson J, Jenkins M, Southey M, Walsh M, Buchanan D, Barker M, Haydon A, Royce S. et al.Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev. 2008;15(7):1774–1780. doi: 10.1158/1055-9965.EPI-08-0091. PubMed DOI

Nosho K, Irahara N, Shima K, Kure S, Kirkner G, Schernhammer E, Hazra A, Hunter D, Quackenbush J, Spiegelman D. et al.Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One. 2008;15(11):1–12. PubMed PMC

Slattery M, Curtin K, Wolff R, Boucher K, Sweeney C, Edwards S, Caan B, Samowitz W. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum. 2009;15(7):1304–1311. doi: 10.1007/DCR.0b013e3181a0e5df. PubMed DOI PMC

Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez N, Chen X, Ahmed S, Konishi K. et al.Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A. 2007;15(47):18654–18659. doi: 10.1073/pnas.0704652104. PubMed DOI PMC

Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Kim GP, Yothers G, Allegra C, Moore MJ. et al.DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst. 2011;15(11):863–875. doi: 10.1093/jnci/djr153. PubMed DOI PMC

van Roon E, van Puijenbroek M, Middeldorp A, van Eijk R, de Meijer E, Erasmus D, Wouters K, van Engeland M, Oosting J, Hes F. et al.Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? BMC Cancer. 2010;15:1–10. doi: 10.1186/1471-2407-10-1. PubMed DOI PMC

Poynter J, Haile R, Siegmund K, Campbell P, Figueiredo J, Limburg P, Young J, Le Marchand L, Potter J, Cotterchio M. et al.Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2009;15(10):2745–2750. doi: 10.1158/1055-9965.EPI-09-0517. PubMed DOI PMC

Worthley DL, Whitehall VL, Spring KJ, Leggett BA. Colorectal carcinogenesis: road maps to cancer. World J Gastroenterol. 2007;15(28):3784–3791. PubMed PMC

Goel A, Xicola R, Nguyen T, Doyle B, Sohn V, Bandipalliam P, Rozek L, Reyes J, Cordero C, Balaguer F. et al.Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2010;15(5):1854–1862. doi: 10.1053/j.gastro.2010.01.035. PubMed DOI PMC

Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn. 2000;15(1):20–28. doi: 10.1016/S1525-1578(10)60611-3. PubMed DOI PMC

Spurgeon SL, Jones RC, Ramakrishnan R. High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS One. 2008;15(2):e1662. doi: 10.1371/journal.pone.0001662. PubMed DOI PMC

Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;15(11):1427–1431. doi: 10.1093/bioinformatics/18.11.1427. PubMed DOI

Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, Washington MK, Schultenover S, Gautam S, Markowitz SD, Grady WM. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res. 2005;15(3):1203–1209. PubMed

Slyskova J, Korenkova V, Collins AR, Prochazka P, Vodickova L, Svec J, Lipska L, Levy M, Schneiderova M, Liska V. et al.Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas. Clin Cancer Res. 2012;15(21):5878–5887. doi: 10.1158/1078-0432.CCR-12-1380. PubMed DOI

Oster B, Thorsen K, Lamy P, Wojdacz TK, Hansen LL, Birkenkamp-Demtroder K, Sorensen KD, Laurberg S, Orntoft TF, Andersen CL. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer. 2011;15(12):2855–2866. doi: 10.1002/ijc.25951. PubMed DOI

Tsai HC, Baylin SB. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 2011;15(3):502–517. doi: 10.1038/cr.2011.24. PubMed DOI PMC

Vasovcak P, Pavlikova K, Sedlacek Z, Skapa P, Kouda M, Hoch J, Krepelova A. Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients. PLoS One. 2011;15(8):e24114. doi: 10.1371/journal.pone.0024114. PubMed DOI PMC

Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, Slattery ML. Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009;15(9):1763–1768. doi: 10.1007/s10552-009-9410-3. PubMed DOI PMC

Takahashi K, Sugi Y, Nakano K, Tsuda M, Kurihara K, Hosono A, Kaminogawa S. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem. 2011;15(41):35755–35762. doi: 10.1074/jbc.M111.271007. PubMed DOI PMC

Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;15(7):484–492. doi: 10.1038/nrg3230. PubMed DOI

Ioana M, Angelescu C, Burada F, Mixich F, Riza A, Dumitrescu T, Alexandru D, Ciurea T, Cruce M, Saftoiu A. MMR gene expression pattern in sporadic colorectal cancer. J Gastrointestin Liver Dis. 2010;15(2):155–159. PubMed

Caradec J, Sirab N, Revaud D, Keumeugni C, Loric S. Is GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments? Br J Cancer. 2010;15(9):1475–1476. doi: 10.1038/sj.bjc.6605851. PubMed DOI PMC

Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, Schernhammer ES, Hunter DJ, Giovannucci EL, Fuchs CS. et al.Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer. 2010;15:125. doi: 10.1186/1476-4598-9-125. PubMed DOI PMC

Ide T, Kitajima Y, Ohtaka K, Mitsuno M, Nakafusa Y, Miyazaki K. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer. Oncol Rep. 2008;15(6):1571–1576. PubMed

Tentori L, Muzi A, Dorio AS, Dolci S, Campolo F, Vernole P, Lacal PM, Praz F, Graziani G. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination. Cancer Chemother Pharmacol. 2013;15(1):117–125. doi: 10.1007/s00280-013-2175-0. PubMed DOI

Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH. Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol. 2001;15(2):171–178. doi: 10.1002/path.918. PubMed DOI

Jiricny J. MutLalpha: at the cutting edge of mismatch repair. Cell. 2006;15(2):239–241. doi: 10.1016/j.cell.2006.07.003. PubMed DOI

Vageli DP, Giannopoulos S, Doukas SG, Kalaitzis C, Giannakopoulos S, Giatromanolaki A, Koukoulis GK, Touloupidis S. Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium. Oncol Lett. 2013;15(1):283–294. PubMed PMC

Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003;15(6):1174–1179. doi: 10.1200/JCO.2003.04.060. PubMed DOI

Martin-Lopez JV, Fishel R. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome. Fam Cancer. 2013;15(2):159–168. doi: 10.1007/s10689-013-9635-x. PubMed DOI PMC

Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers